Recombinant Bovine PIGR Protein，His

PIGR, or Polymeric Immunoglobulin Receptor, is a key protein involved in the transport of immunoglobulins across epithelial cells, facilitating the secretion of immune antibodies, particularly IgA, into mucosal surfaces. The significance of PIGR in immune responses, mucosal immunity, and pathogen defense has garnered attention in recent years, especially considering its potential impact on vaccine development and therapeutic interventions. Research has shown that PIGR plays a vital role in maintaining the balance of immune responses in various mucosal tissues, including the gut, respiratory tract, and salivary glands. Abnormalities in PIGR expression or function have been linked to several immunological disorders and infectious diseases, highlighting the need for a deeper understanding of this receptor. Additionally, recombinant PIGR (rPIGR) generated through biotechnology offers promising avenues for investigating its mechanisms and functions, paving the way for new strategies in immunotherapy and vaccine design. By studying rPIGR's interactions with different immunoglobulins and its role in epithelial transport, researchers aim to elucidate its involvement in mucosal immunity, which could lead to novel therapeutic applications in treating infections and enhancing immune responses. The ongoing research into rPIGR not only enhances our understanding of mucosal biology but also promises to bridge gaps in developing effective vaccines and immunomodulatory therapies, making it a focal point in molecular immunology and translational medicine efforts.